Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressive Disorder, Treatment-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05887310
What this trial is testing

In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells

Who this might be right for
Depressive Disorder, Treatment-Resistant
University of Milano Bicocca 50
Post-approval studies (Phase 4)UnknownNCT02610712
What this trial is testing

Clinical Trial of the Use of Ketamine in Treatment Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
National Institute of Neurology and Neurosurgery, Mexico 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07052058
What this trial is testing

Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)

Who this might be right for
Treatment-Resistant Major Depressive Disorder
Hospital de Clinicas de Porto Alegre 32
Not applicableStudy completedNCT07274917
What this trial is testing

Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression

Who this might be right for
Treatment-Resistant DepressionDepressive Disorder
Capital Medical University 9
Post-approval studies (Phase 4)Study completedNCT00220636
What this trial is testing

Abilify as an Adjunctive Treatment for Refractory Depression

Who this might be right for
Depressive Disorder, Major
St. Luke's-Roosevelt Hospital Center 15
Early research (Phase 1)Study completedNCT02911597
What this trial is testing

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

Who this might be right for
Depression
Stanford University 16
Not applicableStudy completedNCT01431573
What this trial is testing

Wake Therapy in the Treatment of Depression

Who this might be right for
Major Depressive DisorderBipolar Disorder
New York State Psychiatric Institute 8
Early research (Phase 1)Study completedNCT01546051
What this trial is testing

BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers

Who this might be right for
Healthy
BrainCells Inc. 31
Not applicableNot Yet RecruitingNCT07528157
What this trial is testing

Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
Stanford University 80
Not applicableStudy completedNCT00711737
What this trial is testing

Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months

Who this might be right for
Major DepressionGeneralized Anxiety DisorderPanic Disorder
Changi General Hospital 27
Not applicableStudy completedNCT04342299
What this trial is testing

The Antidepressant Advisor (Study 3): fMRI Study to Predict Treatment Response in Patients With Depression

Who this might be right for
Major Depressive Disorder
King's College London 45
Not applicableLooking for participantsNCT07603804
What this trial is testing

Accelerated iTBS for Major Depression

Who this might be right for
Major Depressive Disorder (MDD)Treatment Resistant Depression (TRD)
Istanbul University - Cerrahpasa 35
Large-scale testing (Phase 3)Study completedNCT00044681
What this trial is testing

The Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, MajorDepression
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 258
Not applicableUnknownNCT05809609
What this trial is testing

Glutamate Emotion Memory Study

Who this might be right for
Treatment Resistant DepressionDepressionMajor Depressive Disorder
University of Oxford 60
Not applicableUnknownNCT03972033
What this trial is testing

RCT Comparing EMDR and CBT for Treatment of Resistant Depression

Who this might be right for
Eye Movement Desensitization and ReprocessingCognitive Behavioral TherapyNeurobiological Processing+4 more
University of Turin, Italy 128
Not applicableUnknownNCT03786614
What this trial is testing

Antidepressant Discontinuation in Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
University of Louisville 30
Post-approval studies (Phase 4)Study completedNCT00021528
What this trial is testing

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

Who this might be right for
Depression
National Institute of Mental Health (NIMH) 4,000
Testing effectiveness (Phase 2)Study completedNCT01282632
What this trial is testing

Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

Who this might be right for
Subjects Had Unipolar, Non-psychotic Major Depression
Sunnybrook Health Sciences Centre 42
Large-scale testing (Phase 3)Study completedNCT00770783
What this trial is testing

Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression

Who this might be right for
Major Depression
University Hospital, Bonn 30
Large-scale testing (Phase 3)WithdrawnNCT04924257
What this trial is testing

ECT vs. Esketamine

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Medical University Innsbruck
Next Page